1. Guilleminault C, Tilkian A, Dement WC. The sleep apnea syndromes. Ann Rev Med 1976; 27:465-484.
2. Bassiri AG, Guilleminault C. Clinical features of evaluation of obstructive sleep apnea-hypopnea syndrome. In: Kryger MH, Roth T, Dement WC, eds. Principles and Practices of Sleep Medicine. 3rd ed. Philadelphia, PA: Saunders, 2000:868-878.
3. Philip P, Stoohs R, Guilleminault C. Sleep fragmentation in normals. Sleep 1994; 17:242-247.
4. Chugh DK, Weaver TE, Dinges DF. Neurobehavioral consequences of arousals. Sleep 1996; 19(suppl):S198-S201.
5. Peker Y, Hedner J, Norum J, Kraiczi H, Carlson J. Increased incidence of cardiovascular disease in middle-aged men with obstructive sleep apnea: a 7-year follow-up. Am J Respir Crit Care Med 2002; 166:159-165.
6. Peppard PE, Young T, Palta M, Skatrud J. Prospective study of the association between sleep-disordered breathing and hypertension. N Engl J Med 2000; 342:1378-1384.
7. Javaheri S, Parker TJ, Wexler L, et al. Occult sleep-disordered breathing in stable congestive heart failure. Ann Int Med 1995; 122:487-492.
8. Gami AS, Pressman G, Caples SM, et al. Association of atrial fibrillation and obstructive sleep apnea. Circulation 2004; 110:364-367.
10. Marin JM, Santiago JC, Vicente E, Agusti AGN. Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study. Lancet 2005; 365:1046-1053.
11. Strollo PJ, Roberts RM. Obstructive sleep apnea. N Engl J Med 1996; 334:99-104.
12. Sullivan CE, Issa FG, Berthon-Jones M, Eves L. Reversal of obstructive sleep apnoea by continuous positive airway pressure applied through the nares. Lancet 1981; 1:862-865.
13. Abbey NC, Cooper KR, Kwentus JA. Benefit of nasal CPAP in obstructive sleep apnea is due to positive pharyngeal pressure. Sleep 1989; 12:420-422.
14. Loredo JS, Anocli-Israel S, Dimsdale JE. Effect of continuous positive airway pressure vs placebo continuous positive airway pressure on sleep quality in obstructive sleep apnea. Chest 1999; 116:1545-1549.
15. McArdle N, Douglas NJ. Effect of continuous positive airway pressure on sleep architecture in the sleep apnea-hypopnea syndrome: a randomized controlled trial. Am J Respir Crit Care Med 2001; 164:1459-1463.
16. Patel SR, White DP, Malhotra A, Stanchina ML, Ayas NT. Continuous positive airway pressure therapy for treating sleepiness in a diverse population with obstructive sleep apnea: results of a meta-analysis. Arch Intern Med 2003; 163:565-571.
17. Morisson F, Decary A, Petit D, Lavigne G, Malo J, Montplaisir J. Daytime sleepiness and EEG spectral analysis in apneic patients before and after treatment with continuous positive airway pressure. Chest 2001; 119:45-52.
18. Engelman HM, Kingshott RN, Wraith PK, Mackay TW, Deary IJ, Douglas NJ. Randomized placebo-controlled crossover trial of continuous positive airway pressure for mild sleep Apnea/Hypopnea syndrome. Am J Respir Crit Care Med 1999; 159: 461-467.
19. Engleman HM, Martin SE, Deary IJ, Douglas NJ. Effect of continuous positive airway pressure treatment on daytime function in sleep apnoea/hypopnea syndrome. Lancet 1994; 343:572-575.
20. Engleman HM, Martin SE, Deary IJ, Douglas NJ. Effect of CPAP therapy on daytime function in patients with mild sleep apnoea/hypopnoea syndrome. Thorax 1997; 52:114-119.
21. Suzuki M, Otsuka K, Guilleminault C. Long-term nasal continuous positive airway pressure administration can normalize hypertension in obstructive sleep apnea patients. Sleep 1993; 16:545-549.
22. Dimsdale JE, Loredo JS, Profant T, et al. Effect of nasal continuous positive airway pressure on blood pressure: a placebo trial. Hypertension 2000; 35:144-147.
23. Diomedi M, Placidi F, Cupini LM, et al. Cerebral hemodynamic changes in sleep apnea syndrome and effect of continuous positive airway pressure treatment. Neurology 1998; 51:1051-1056.
24. Alchanatis M, Tourkohoriti G, Kakouros S, et al. Daytime pulmonary hypertension in patients with obstructive sleep apnea: the effect of continuous positive airway pressure on pulmonary hemodynamics. Respiration 2001; 68:566-572.
25. Becker H, Brandenburg U, Peter JH, et al. Reversal of sinus arrest and atrioventricular conduction block in patients with sleep apnea during nasal continuous positive airway pressure. Am J Respir Crit Care Med 1995; 151:2215-2218.
26. Stegman SS, Burroughs JM, Henthorn RW. Asymptomatic bradyarrhythmias as a marker for sleep apnea: appropriate recognition and treatment may reduce the need for pacemaker therapy. Pacing Clin Electrophysiol 1996; 19:899-904.
27. Kanagala R, Murali NS, Friedman PA, et al. Obstructive sleep apnea and the recurrence of atrial fibrillation. Circulation 2003; 107:2589-2594.
28. Harbison J, O'Reilly P, McNicholas WT. Cardiac rhythm disturbances in the obstructive sleep apnea syndrome: effects of nasal continuous positive airway pressure therapy. Chest 2000; 118:591-595.
29. Javaheri S. Effects of continuous positive airway pressure on sleep apnea and ventricular irritability in patients with heart failure. Circulation 2000; 169:156-162.
30. Malone S, Liu PP, Holloway R, et al. Obstructive sleep apnoea in patients with dilated cardiomyopathy: effects of continuous positive airway pressure. Lancet 1991; 338:1480-1484.
31. Kaneko Y, Floras JS, Usui K, et al. Cardiovascular effects of continuous positive airway pressure in patients with heart failure and obstructive sleep apnea. N Engl J Med 2003; 348:1233-1241.
Sanner BM, Konermann M, Tepel M, et al. Platelet function in patients with obstructive sleep apnea in ischemic stroke. Am J Respir Crit Care Med 2000; 22:21-27.
Chin K, Kita H, Noguchi T, et al. Improvement of factor VII clotting activity following long-term NCPAP treatment in obstructive sleep apnoea syndrome. QJM 1998;
Chin K, Ohi M, Kita H, et al. Effects of NCPAP therapy on fibrinogen levels in obstructive sleep apnea syndrome. Am J Respir Crit Care Med 1996; 153:1972-1976. Ohike Y, Kozaki K, Iijima K, et al. Amelioration of vascular endothelial dysfunction in obstructive sleep apnea syndrome by nasal continuous positive airway pressure—possible involvement of nitric oxide and symmetric NG, NG-dimethylarginine. Circ J 2005; 32(11 suppl):S548-S553.
Zhang XL, Yin KS, Mao H, Wang H, Yang Y. Effect of continuous positive airway pressure treatment on vascular endothelial function in patients with obstructive sleep apnea hypopnea syndrome and coronary artery disease. Chin Med J 2004; 117:844-847. Narkiewicz K, de Borne PJH, Cooley RL, Dyken ME, Somers VK. Sympathetic activity in obese subjects with and without obstructive sleep apnea. Circulation 1998; 98:772-776.
Usui K, Bradley TD, Spaak J, et al. Inhibition of awake sympathetic nerve activity of heart failure patients with obstructive sleep apnea by nocturnal continuous positive airway pressure. J Am Coll Cardiol 2005; 45:2008-2011.
Harsch IA, Pour Schahin S, Radespiel-Troger M, et al. Continuous positive airway pressure treatment rapidly improves insulin sensitivity in patients with obstructive sleep apnea syndrome. Am J Respir Crit Care Med 2004; 169:156-162.
Yokoe T, Minoguchi K, Matsuo H, et al. Elevated levels of C-reactive protein and inter-leukin-6 in patients with obstructive sleep apnea syndrome are decreased by nasal continuous positive airway pressure. Circulation 2003; 107:1129-1134. Ip MS, Lam KS, Ho C, Tsang KW, Lam W. Serum leptin and vascular risk factors in obstructive sleep apnea. Chest 2000; 118:569-571.
Chin K, Shinizu K, Nakamura T, et al. Changes in intra-abdominal visceral fat and serum leptin levels in patients with obstructive sleep apnea syndrome following nasal continuous positive airway pressure therapy. Circulation 1999; 100:706-712. Kushida CA, Littner MR, Hirshkowitz M, et al. Practice parameters for the use of continuous and bilevel positive airway pressure devices to treat adult patients with sleep-related breathing disorders. Sleep 2006; 29:375-380.
Young T, Peppard PE, Gottlieb DJ. Epidemiology of obstructive sleep apnea: a population health perspective. Am J Respir Crit Care Med 2002; 165:1217-1239. Javaheri S. Sleep disorders in systolic heart failure: a prospective study of 100 male patients. The final report. Int J Cardiol 2006; 106:21-28.
Schafer H, Koehler U, Ewig S, et al. Obstructive sleep apnea as a risk marker in coronary artery disease. Cardiology 1999; 92:79-84.
Centers for Medicare and Medicaid Services Manual. Section 60-17. Revised April 1, 2002.
Centers for Medicare and Medicaid Services. Empire Medicaid Services: Local coverage determination. Last review March 9, 2006. www.empiremedicare.com/newypolicy/ policy/|8201_final.htm.
Young T, Palta M, Dempsey J, Skatrud J, Weber S, Badr S. The occurrence of sleep-disordered breathing among middle-aged adults. N Engl J Med 1993; 328(17):1230-1235. Guilleminault C, Stoohs R, Clark A, et al. A cause of excessive daytime sleepiness: the upper airway resistance syndrome. Chest 1993; 104:781-787.
Suratt PM, Turner BL, Withoit SC. Effect of intranasal obstruction on breathing during sleep. Chest 1986; 90:324-329.
Issa F, Sullivan C. Reversal of central sleep apnea using nasal CPAP. Chest 1986; 90:165-171.
Guilleminualt C, Stoohs R, Shnieder H, et al. Central alveolar hypoventilation and sleep: treatment by intermittent positive pressure ventilation through nasal mask in an adult. Chest 1989; 96:1210-1212.
McNicholas W, Carter J, Rutherford R, et al. Beneficial effect of oxygen in primary alveolar hypoventilation with central sleep apnea. Am Rev Respir Dis 1982; 125:773-775.
55. White D, Zwillich C, Pickett C, et al. Central sleep apnea: improvement with acetazola-mide therapy. Arch Intern Med 1982; 142:1816-1819.
56. Guilleminault C, van den Hoed J, Mitler M. Clinical overview of the sleep apnea syndromes. In: Guilleminault C, Dement W, eds. Sleep Apnea Syndromes. New York: Alan R Liss, 1978:1-11.
57. Sin DD, Fitzgeral F, Parker JD, et al. Risk factors for central and obstructive sleep apnea in 450 men and women with congestive heart failure. Am J Respir Crit Care Med 1999; 160:1101-1106.
58. Lofaso F, Verschueren P, Rande JL, Harf A, Goldenberg F. Prevalence of sleep-disordered breathing in patients on a heart transplant waiting list. Chest 1994; 106:1689-1694.
59. Hanly PJ, Zuberi-Khokar NS. Increased mortality associated with Cheyne-Stokes respiration in patients with congestive heart failure. Am J Respir Crit Care Med 1996; 153:272-276.
60. Tremel F, Pepin J, Veale D, et al. High prevalence and persistence of sleep apnoea in patients referred for acute left ventricular failure and medically treated over 2 months. Eur Heart J 1999; 20:1201-1209.
61. Naughton MT, Lie PP, Bernard DC, et al. Treatment of congestive heart failure and Cheyne-Stokes respiration during sleep by continuous positive airway pressure. Am J Respir Crit Care Med 1995; 151:92-97.
62. Kaye DM, Mansfield D, Aggarwal A, et al. Acute effects of continuous positive airway pressure on cardiac sympathetic tone in congestive heart failure. Circulation 2001; 103:2336-2338.
63. Sn DD, Logan AG, Fitgerald FS, et al. Effects of continuous positive airway pressure on cardiovascular outcomes in heart failure patients with and without Cheyne-Stokes respiration. Circulation 2000; 102:61-66.
64. Bradley TD, Logan AG, Kimoff RJ, et al. Continuous positive airway pressure for central sleep apnea and heart failure. N Engl J Med 2005; 353:2025-2033.
65. Pepperell JC, Maskell NA, Jones DR, et al. A randomized controlled trial of adaptive ventilation for Cheyne-Stokes Breathing in heart failure. Am J Respir Crit Care Med 2003; 168:1109-1114.
66. Teschler H, Dohring J, Wang YM, Berthon-Jones M. Adaptive pressure support servo-ventilation: a novel treatment for Cheyne-Stokes breathing in heart failure. Am J Respir Crit Care Med 2003; 168:1109-1114.
67. Philippe C, Stoica-Herman, Drouot X, et al. Compliance with and effectiveness of adaptive servo-ventilation versus continuous positive airway pressure in the treatment of Cheyne-Stokes respiration in heart failure over a six month period. Heart 2006; 92:337-342.
68. Rich S, ed. Primary pulmonary hypertension: executive summary from the World Symposium on Primary Pulmonary Hypertension. Geneva, World Health Organization, 1998.
69. Sanner BM, Doberauer C, Konermann M, et al. Pulmonary hypertension in patients with obstructive sleep apnea syndrome. Arch Intern Med 1997; 157:2483-2487.
70. Chaouat A, Weitzenblum E, Krieger J, et al. Pulmonary hemodynamics in the obstructive sleep apnea syndrome. Chest 1996; 109:380-386.
71. Laks L, Lehrhaft B, Grunstein RR, et al. Pulmonary hypertension in obstructive sleep apnea. Eur Respir J 1995; 8:537-541.
72. Catterall JR, Douglas NJ, Calverley PM, et al. Transient hypoxemia during sleep in chronic obstructive pulmonary disease is not a sleep apnea syndrome. Am Rev Respir Dis 1983; 128:24-29.
73. Catterall JR, Calverley PM, MacNee W, et al. Mechanism of transient nocturnal hypoxemia in hypoxic chronic bronchitis and emphysema. J Appl Physiol 1985; 59:1698-1703.
74. Lighttowler JV, Wedzicha JA, Elliot MW, Ramm FS. Non-invasive pressure ventilation to treat respiratory failure from exacerbations of chronic obstructive pulmonary disease: Cochrane systematic review and meta-analysis. Br Med J 2003; 326:185-187.
75. Meecham Jones DJ, Paul EA, Jones PW, Wedzicha JA. Nasal pressure support ventilation plus oxygen compared with oxygen therapy alone in hypercapnic COPD. Am J Respir Crit Care Med 1995; 152:538-544.
Perez de Llano LA, Golpe R, Ortiz Piquer M, et al. Short-term and long-term effects of nasal intermittent positive pressure ventilation in patients with obesity-hypoventila-tion syndrome. Chest 2005; 128:587-594.
Mezon BL, West P, Israels J, et al. Sleep breathing abnormalities in kyphoscoliosis. Am Rev Respir Dis 1980; 122:617.
Guilleminault C, Kurland G, Winkle R, et al. Severe kyphoscoliosis, breathing, and sleep: The "Quasimodo" syndrome during sleep. Chest 1981; 79:6.
Hill NS, Eveloff SE, Carlisle CC, et al. Efficacy of nocturnal nasal ventilation in patients with restrictive thoracic disease. Am Rev Respir Dis 1992; 145:365-371.
Buyse B, Meersseman W, Demedts M. Treatment of chronic respiratory failure in kypho-
scoliosis: oxygen or ventilation? Eur Respir J 2003; 22:525-528.
Masa JF. Noninvasive positive pressure ventilation and not oxygen may prevent overt ventilatory failure in patients with chest wall disease. Chest 1997; 112:201-213. Ward S, Chatwin M, Heather S, Simonds AK. Randomised controlled trial of non-invasive ventilation (NIV) for nocturnal hypoventilation in neuromuscular and chest wall disease patients with daytime normocapnia. Thorax 2005; 60:1019-1024. Konagaya M, Sakai M, Wakayama T, et al. Effect of intermittent positive pressure ventilation on lifespan and causes of death in Duchenne muscular dystrophy. Rinsho Shinkeigaku 2005; 45:643-646.
Perez-Padilla R, West P, Lertzman M, et al. Breathing during sleep in patients with interstitial lung disease. Am Rev Respir Dis 1985; 132:224-229.
Tatsumi K, Kimuar H, Kunitomo F, et al. Arterial oxygen desaturation during sleep in interstitial pulmonary disease: correlation with chemical control of breathing during wakefulness. Chest 1989; 95:962-967.
Crockett AJ, Cranston JM, Antic N. Domiciliary oxygen for interstitial lung disease. Cochrane Database Syst Rev 2001; (3):CD002883.
Means MK, Edinger JD, Husain AM. CPAP compliance in sleep apnea patients with and without laboratory CPAP titration. Sleep Breath 2004; 8:7-14.
Zozula R, Rosen R. Compliance with continuous positive airway pressure therapy: assessing and improving treatment outcomes. Curr Opin Pulm Med 2001; 7:391-398. Hoy CJ, Vennelle M, Kingshott RN, et al. Can intensive support improve continuous positive airway pressure use in patients with the sleep apnea/hypopnea syndrome? Am J Respir Crit Care Med 1999; 159:1096-1100.
Lewis KE, Seale L, Bartle IE, et al. Early predictors of CPAP use for the treatment of obstructive sleep apnea. Sleep 2004; 27:134-138.
Bachour A, Hurmerinta K, Maasilta P. Mouth closing device (chinstrap) reduces mouth leak during nasal CPAP. Sleep Med 2004; 5:261-267.
Bachour A, Maasilta P. Mouth breathing comprises adherence to nasal continuous positive airway pressure. Chest 2004; 126:1248-1254.
Montserrat JM, Ballester E, Olivi H, et al. Time-course of stepwise CPAP titration: behavior of respiratory and neurological variables. Am J Respir Crit Care Med 1995; 152:1854-1859.
Hosselet JJ, Norman RG, Ayappa I, et al. Detection of flow limitation with a nasal cannula/pressure transducer system. Am J Respir Crit Care Med 1998; 157:1461-1467. Meurice JC, Paquereau J, Denjean A, et al. Influence of correction of flow limitation on continuous positive airway pressure efficiency in sleep apnoea/hyponoea syndrome. Eur Respir J 1998:1121-1127.
Miles LE, Crichton DA, Vishnevskaya Z. Sustained inspiratory airflow limitation: a preferred measure of partial upper airway obstruction. J Sleep Res 2000; 11(suppl 1):156. Bureau MP, Series F. Comparison of two in-laboratory titration methods to determine effective pressure levels in patients with obstructive sleep apnoea. Thorax 2000; 55:741-745.
Pevernagie DA, Shepard JW Jr. Relations between sleep stage, posture and effective nasal CPAP levels in OSAHS. Sleep 1992; 15:162-167.
Marrone O, Insalaco G, Bonsignore MR, et al. Sleep structure correlates of continuous positive airway pressure variations during application of an autotitrating continuous positive airway pressure machine in patients with obstructive sleep apnea syndrome. Chest 2002; 121:759-767.
100. Issa FG, Sullivan CE. The immediate effects of nasal continuous positive airway pressure treatment on sleep pattern in patients with obstructive sleep apnea syndrome. Electroencephalogr Clin Neurophysiol 1986; 63:10-17.
101. Leevers AM, Simon PM, Dempsey JA. Apnea after normocapnic mechanical ventilation during NREM sleep. J Appl Physiol 1994; 77:2079-2085.
102. Schwab RJ, Gefter WB, Hoffman EA, et al. Dynamic upper airway imaging during awake respiration in normal subjects and patients with sleep disordered breathing. Am Rev Respir Dis 1985; 131:401-408.
103. Sanders MH, Kern N. Obstructive sleep apnea treated by independently adjusted inspiratory and expiratory positive airway pressures via nasal mask: physiologic and clinical implications. Chest 1990; 98:317-324.
104. Johnson KG, Johnson DC. Bilevel positive airway pressure worsens central apneas during sleep. Chest 2005; 128:2141-2150.
105. Gay P, Weaver T, Loube D, Iber C. Evaluation of positive airway pressure treatment for sleep related breathing disorders in adults: a review by the positive airway pressure task force of the Standards of Practice Committee of the American Academy of Sleep Medicine. Sleep 2006; 29:381-401.
106. Fleury B, Rakotonanahary D, Tehindrazanarivedlo AD, et al. Long term compliance to continuous positive airway pressure therapy (nCPAP) set up during a split-night polysomnography. Sleep 1994; 17:512-515.
107. Sanders MH, Kern NB, Costantino JP, et al. Adequacy of prescribing positive airway pressure therapy by mask for sleep apnea on the basis of a partial-night trial. Am Rev Respir Dis 1993; 147:1169-1174.
108. Rosenthal L, Nykamp K, Guido P, et al. Daytime CPAP titration: a viable alternative for patients with severe obstructive sleep apnea. Chest 1998; 114:1056-1060.
109. Rudkowski JC, Verschelden P, Kimoff RJ. Efficacy of daytime continuous positive airway pressure titration in severe obstructive sleep apnoea. Eur Respir J 2001; 18:535-541.
110. Jokic R, Klimaszewski A, Sridhar G, et al. Continuous positive airway pressure requirement during the first month of treatment in patients with severe obstructive sleep apnea. Chest 1998; 114:1061-1069.
111. Miljeteigh H, Hoffstein V. Continuous positive airway pressure for treatment of obstructive sleep apnea. Am Rev Respir Dis 1993; 147:1526-1530.
112. Berry RB, Desa MM, Lights RW. Effect of ethanol on the efficacy of nasal continuous positive airway pressure as a treatment for obstructive sleep apnea. Chest 1991; 99:339-343.
113. Engleman HM, Asgari-Jirhandeh N, McLeod AL, et al. Self-reported use of CPAP and benefits of CPAP therapy: a patient survey. Chest 1996; 109:1470-1476.
114. Strollo PJ Jr, Sanders MH, Atwood CW. Positive pressure therapy. Clin Chest Med 1998; 19:55-68.
115. Pepin JL, Leger P, Veale D, et al. Side effects of nasal continuous positive airway pressure in sleep apnea syndrome: study of 193 patients in two French sleep centers. Chest 1995; 107:375-381.
116. Richards GN, Cistulli PA, Ungar RG, et al. Mouth leak with continuous positive airway pressure increases nasal airway resistance. Am J Respir Crit Care Med 1996; 154:182-186.
117. Herrejon SA, Inchaurraga AI, Gonzalez M. Spontaneous pneumothorax associated with the use of nighttime BiPAP with a nasal mask. Arch Bronceneumol 1998; 34:512.
118. Alvarez-Sala R, Diaz S, Prados C, et al. Increase of intraocular pressure during nasal continuous positive pressure in a patient with sleep apnea syndrome. Chest 1992; 101:1477.
119. Jarjour NN, Wilson P. Pneumocephalus associated with nasal continuous positive airway pressure in a patient with sleep apnea syndrome. Chest 1989; 96:1425-1426.
120. Nowak C, Bourgin P, Portier F, et al. Nasal obstruction and compliance to nasal positive airway pressure. Ann Otolaryngol Chir Cervicofac 2003; 120:161-166.
121. Brouillette RT, Fernback SK, Hunt CE. Obstructive sleep apnea in infants and children. J Pediatric 1982; 100:31-40.
122. Suen JS, Arnold JE, Brooks LJ. Adenotonsillectomy for treatment of obstructive sleep apnea in children. Arch Otolaryngol Head Neck Surg 1995; 121:525-530.
O'Donnell AR, Bjornson CL, Bohn SG, Kirk VG. Compliance rates in children using noninvasive continuous positive airway pressure. Sleep 2006; 29:651-658. Marcus CL, Ward SL, Mallory GB, et al. Use of nasal continuous positive airway pressure as treatment of childhood obstructive sleep apnea. J Pediatr 1995; 127:88-94. Hers V, Liistro G, Dury M, et al. Residual effect of nCPAP applied for part of the night in patients with obstructive sleep apnoea. Eur Respir J 1997; 10:973-976. Gupta RM, Parvizi J, Hanssen AD, Gay PC. Postoperative complications in patients with obstructive sleep apnea syndrome undergoing hip or knee replacement: a case control study. Mayo Clin Proc 2001; 76:897-905.
Gross JB, Bachenberg KL, Benumof JL, et al. Practice guidelines for the perioperative management of patients with obstructive sleep apnea: a report by the American Society of Anesthesiologists Task Force on Perioperative Management of patients with obstructive sleep apnea. Anesthesiology 2006; 104:1081-1093.
Montserrat JM, Ferrer M, Hernandez L, et al. Effectiveness of CPAP treatment in daytime function in sleep apnea syndrome. A randomized controlled study with an optimized placebo. Am J Respir Crit Care Med 2001; 164:608-613.
Engleman HM, McDonald JP, Graham D, et al. Randomized crossover trial of two treatments for sleep apnea/hypopnea syndrome: continuous positive airway pressure and mandibular repositioning splint. Am J Respir Crit Care Med 2002; 166:855-859. Redline S, Adams N, Strauss ME, et al. Improvement of mild sleep-disordered breathing with CPAP compared with conservative therapy. Am J Respir Crit Care Med 1998; 157:858-865.
McArdle N, Devereux G, Heidarnejad H, et al. Long-term use of CPAP therapy for sleep apnea/hypopnea syndrome. Am J Respir Crit Care Med 1999; 159:1108-1114. Kribbs NB, Pack AI, Kline LR, et al. Objective measurement of patterns of nasal CPAP use by patients with obstructive sleep apnea. Am Rev Respir Dis 1993; 147:887-895. DiMatteo MR. Variation in patients' adherence to medical recommendations: a quantitative review of 50 years of research. Medical Care 2004; 42(3):200-209. Campos-Rodriguez F, Pena-Grinan N, Reyes-Nunez N, et al. Mortality in obstructive sleep apnea-hypopnea patients treated with positive airway pressure. Chest 2005; 128:624-633.
Weaver TE. How much is enough CPAP? Sleep Med 2003; 4:S52.
Burke LE, Ockene IS. Compliance in healthcare and research. Armonk, NY: Futura Publishing Co., 2001.
Engleman HM, Martin SE, Douglas NJ. Compliance with CPAP therapy in patients with sleep apnoea/hypopnoea syndrome. Thorax 1994; 49:263-266. Massie C, Hart R, Peralez K, et al. Effects of humidification on nasal symptoms and compliance in sleep apnea patients using continuous positive airway pressure. Chest 1999; 116:403-408.
Mortimore IL, Whittle AT, Douglas NJ. Comparison of nose and face mask CPAP therapy for sleep apnoea. Thorax 1998; 53:290-292.
Hudgel DW, Fung C. A long-term randomized, cross-over comparison of auto-titrating and standard nasal continuous positive airway pressure. Sleep 2000; 23:645-648. Reeves-Hoche MK, Hudgel DW, Meck R, et al. Continuous versus bilevel positive airway pressure for obstructive sleep apnea. Am J Respir Crit Care Med 1995; 151:443-449.
Stepnowsky CJ Jr, Marler MR, Ancoli-Israel S. Determinants of nasal CPAP compliance. Sleep Med 2002; 3:239-247.
Aloia MS, Arnedt JT, Stepnowsky CJ Jr, et al. Predicting treatment adherence in obstructive sleep apnea using principles of behavior change. J Clin Sleep Med 2005; 1:247-254.
Engleman H, Wild MR. Improving CPAP use by patients with the sleep apnoea/hypopnoea syndrome (SAHS). Sleep Med Rev 2003; 7:81-99.
Haniffa M, Lasserson TJ, Smith I. Interventions to improve compliance with continuous positive airway pressure for obstructive sleep apnoea (Review). Cochrane Database Syst Rev Wiley, October 18, 2004; CD003531:1-58.
146. Teschler H, Berthon-Jones M, Thompson AB, et al. Automated continuous positive airway pressure titration for obstructive sleep apnea syndrome. Am J Respir Crit Care Med 1996; 154:734-740.
147. Ayas NT, Patel SR, Malhotra A, et al. Auto-titrating versus standard continuous positive airway pressure for the treatment of obstructive sleep apnea: results of a meta-analysis. Sleep 2004; 27:249-253.
148. Aloia MS, Stanchina ML, Arnedt JT, et al. Treatment adherence and outcomes in flexible versus continuous positive airway pressure therapy. Chest 2005; 127:2085-2093.
149. Worsnop C, Miseski S, Rochford P. Humidification of continuous positive airway pressure treatment in sleep apnoea reduces nasal symptoms. Proceedings of the Thoracic Society of Australia and New Zealand, Adelaide, 2003:178.
150. Fletcher EC, Luckett RA. The effect of positive reinforcement on hourly compliance in nasal continuous positive airway pressure users with obstructive sleep apnea. Am Rev Respir Dis 1991; 143:936-941.
151. Likar LL, Panciera TM, Erickson AD, et al. Group education sessions and compliance with nasal CPAP therapy. Chest 1997; 111:1273-1277.
152. Chervin RD, Theut S, Bassetti C, et al. Compliance with nasal CPAP can be improved by simple interventions. Sleep 1997; 20:284-289.
153. Hoy CJ, Vennelle M, Kingshott RN, et al. Can intensive support improve continuous positive airway pressure use in patients with the sleep apnea/hypopnea syndrome? Am J Respir Crit Care Med 1999; 159:1096-1871.
154. Hui DSC, Chan JKW, Choy DKL, et al. Effects of augmented continuous positive airway pressure education and support on compliance and outcome in a Chinese population. Chest 2000; 117:1410-1416.
155. Aloia MS, Arnedt JT, Riggs RL, et al. Clinical management of poor adherence to CPAP: motivational enhancement. Behav Sleep Med 2004; 2:205-222.
156. Stepnowsky CJ Jr, Ancoli-Israel S. CPAP adherence is associated with the decisional balance index [Abstract]. Sleep 2000; 23:A287-A288.
157. Aloia MS, Smith K, Arnedt JT, et al. Brief behavioral therapies reduce early PAP discontinuation rates in SAS: preliminary findings. Behav Sleep Med. In press.
Was this article helpful?